| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 16.350 | 20.852 | 20.372 | 22.893 | 20.795 | 15.391 | 21.666 | 23.052 | 21.330 | 24.781 |
| Total Income - EUR | 16.496 | 20.852 | 20.372 | 23.319 | 21.892 | 16.697 | 21.666 | 23.052 | 21.410 | 24.781 |
| Total Expenses - EUR | 16.538 | 21.851 | 20.131 | 23.582 | 19.059 | 17.748 | 22.025 | 22.322 | 24.937 | 30.583 |
| Gross Profit/Loss - EUR | -43 | -1.000 | 241 | -264 | 2.832 | -1.051 | -360 | 731 | -3.527 | -5.801 |
| Net Profit/Loss - EUR | -533 | -1.208 | 37 | -497 | 2.478 | -1.175 | -480 | 486 | -3.754 | -6.161 |
| Employees | 3 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Gianimed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 6.285 | 6.221 | 6.116 | 6.004 | 5.888 | 4.726 | 3.932 | 2.735 | 1.621 | 512 |
| Current Assets | 5.033 | 5.444 | 5.899 | 6.305 | 8.413 | 8.049 | 8.801 | 10.407 | 8.050 | 2.680 |
| Inventories | 4.389 | 4.437 | 4.874 | 5.698 | 6.531 | 6.404 | 5.837 | 6.277 | 5.880 | 523 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 401 | 372 | 440 | 555 | 479 |
| Cash | 644 | 1.007 | 1.024 | 607 | 1.883 | 1.244 | 2.592 | 3.690 | 1.614 | 1.678 |
| Shareholders Funds | -24.675 | -25.632 | -25.161 | -25.197 | -22.231 | -22.984 | -22.954 | -22.277 | -25.963 | -31.979 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 35.993 | 37.297 | 37.176 | 37.505 | 36.532 | 35.759 | 35.687 | 35.418 | 35.633 | 35.171 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5630 - 5630" | |||||||||
| CAEN Financial Year |
5630
|
|||||||||
Comments - Gianimed Srl